Purpose Cancer-related fatigue (CRF) is a pervasive symptom experienced by cancer
patients. Sarcopenia has been suggested as a treatment target of CRF. This study aims to …

Background Although exertional fatigue is directly and negatively related to skeletal muscle
mass and strength, it is currently unknown if these variables are associated with cancer …

Introduction Sarcopenia is defined as the loss of muscle mass and muscular functioning.
Although sarcopenia prevalence is highly variable in the literature, pre-chemotherapy …

Background Cancer‐related fatigue (CRF) reduces quality of life and the activity level of
patients with cancer. Cancer related fatigue can be reduced by exercise interventions that …

Background: Sarcopenia, or skeletal muscle loss, is a common problem in post-treatment
cancer patients and can negatively affect physical function and quality of life (QOL). This …

Background Determining the prevalence of fatigue among cancer patients is complicated by
the high prevalence of fatigue symptoms in the general population. The aim of this study was …

Introduction In the older patients with cancer, the combination of aging and cancer makes
sarcopenia more likely to occur. However, previous studies paid less attention to the …

Sarcopenia, characterized by a decline of skeletal muscle plus low muscle strength and/or
physical performance, has emerged to be an important prognostic factor for advanced …

The objective of the present study was to investigate the incidence of and possible risk
factors associated with sarcopenia among cancer patients. Patients with cancer were …

Purpose Assessing physical reserve in older cancer patients before treatment decision-
making remains challenging. The maintenance of physical independence during therapy is …